Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus

William Sedley, Jehill Parikh, Richard A E Edden, Valerie Tait, Andrew Blamire, Timothy D Griffiths, William Sedley, Jehill Parikh, Richard A E Edden, Valerie Tait, Andrew Blamire, Timothy D Griffiths

Abstract

It is not known why tinnitus occurs in some cases of hearing damage but not others. Abnormalities of excitation-inhibition balance could influence whether tinnitus develops and its severity if it does. Animal models of hearing damage, which also produce tinnitus based on behavioral evidence, have identified abnormalities of GABAergic inhibition, both cortically and subcortically. However, the precise relationships of GABA inhibitory changes to tinnitus itself, as opposed to other consequences of hearing damage, remain uncertain. Here, we used magnetic resonance spectroscopy to non-invasively quantify GABA in the left (LAC) and right (RAC) auditory cortices of a group of 14 patients with lateralized tinnitus (eight left ear) and 14 controls matched for age, sex, and hearing. We also explored the potential relationships with other brain metabolites (i.e., choline, N-acetylaspartate, and creatine). The presence of tinnitus was associated with a reduction in auditory cortex GABA concentration. Regardless of tinnitus laterality, post hoc testing indicated reductions that were significant in RAC and nonsignificant in LAC. Tinnitus severity and hearing loss were correlated positively with RAC choline but not GABA. We discuss the results in the context of current models of tinnitus and methodological constraints.

Significance statement: Permanently affecting one in seven adults, tinnitus lacks both widely effective treatments and adequate understanding of its brain mechanisms. Existing animal models represent tinnitus that may not be distinguishable from homeostatic responses to the auditory insults used to induce it. Human studies can be well controlled in this regard but are usually not (with few even matching control subjects for hearing loss) and are limited in scope as a result of relying solely on non-invasive recording techniques. Here, we exploit recent advances in non-invasive spectroscopic techniques to establish, in a human study tightly controlled for hearing loss and hyperacusis, that tinnitus is associated with a significant reduction in auditory cortex GABA concentration, which has implications for understanding and treatment of the condition.

Keywords: GABA; MR spectroscopy; auditory cortex; choline; tinnitus.

Copyright © 2015 Sedley et al.

Figures

Figure 1.
Figure 1.
Example GABA spectrum acquisition from the RAC in one typical subject. A, Orthogonal section view (neurological convention; L, left; R, right) of voxel placement. Voxels were placed parallel with and superiorly abutting the Sylvian fissure and were otherwise centered on Heschl's sulcus. This volume encompassed nearly all of Heschl's gyrus, including the primary auditory cortex, the planum temporale, the superior temporal sulcus, planum polare, and also small parts of the insula and middle temporal gyrus adjacent to these auditory regions. B, Edited spectrum, including the GABA peak for quantification at 3 ppm. C, Expanded view of B, showing 3 ppm GABA peak and fitted Gaussian function used for quantification.
Figure 2.
Figure 2.
Auditory cortex GABA concentrations in the tinnitus and control groups. AC, Auditory cortex. Boxes indicate interquartile range, with horizontal line at the median, and whiskers indicate full range, barring outliers that are indicated with + signs. GABA was significantly reduced (p < 0.05) as a main effect of subject group (tinnitus vs control) and in the RAC. Results displayed here are also tabulated in Table 1.
Figure 3.
Figure 3.
Hearing and tinnitus-related subject characteristics. A, Mean pure tone hearing thresholds of the tinnitus and control groups. Error bars represent SEM. B, Positive nonparametric correlations between hearing and tinnitus measures within the tinnitus group. Significant (p < 0.05 uncorrected) correlations are denoted by asterisks. No negative correlations close to significance were observed, hence only positive correlations are shown. MHL, Mean hearing loss (in decibels; across all frequencies shown in A). Dur, Tinnitus duration (years); OvLoud, overall VAS loudness; CurLoud, current VAS loudness; OvDist, overall VAS tinnitus distress; CurDist, current VAS tinnitus distress.
Figure 4.
Figure 4.
Correlations between choline concentration and subject variables. A, Relationship between mean hearing loss and RAC choline concentration in control (gray) and tinnitus (black) groups. Individual dots denote individual subjects, and lines represent least squares best linear fits. B, Spearman's rank correlation coefficients (ρ) between choline and subjective tinnitus variables in bilateral auditory cortices. OvLoud, VAS overall tinnitus loudness; CurLoud, VAS current tinnitus loudness; CurDist, VAS current tinnitus distress. **p < 0.01 uncorrected.

References

    1. Adjamian P, Sereda M, Zobay O, Hall DA, Palmer AR. Neuromagnetic indicators of tinnitus and tinnitus masking in patients with and without hearing loss. J Assoc Res Otolaryngol. 2012;13:715–731. doi: 10.1007/s10162-012-0340-5.
    1. Bauer CA, Brozoski TJ, Holder TM, Caspary DM. Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hear Res. 2000;147:175–182. doi: 10.1016/S0378-5955(00)00130-1.
    1. Brozoski TJ, Spires TJ, Bauer CA. Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol. 2007;8:105–118. doi: 10.1007/s10162-006-0067-2.
    1. Brozoski T, Odintsov B, Bauer C. Gamma-aminobutyric acid and glutamic acid levels in the auditory pathway of rats with chronic tinnitus: a direct determination using high resolution point-resolved proton magnetic resonance spectroscopy (H-MRS) Front Syst Neurosci. 2012;6:9. doi: 10.3389/fnsys.2012.00009.
    1. Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med. 1986;315:854–859. doi: 10.1056/NEJM198610023151403.
    1. Busto U, Fornazzari L, Naranjo CA. Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines. J Clin Psychopharmacol. 1988;8:359–362.
    1. Cacace AT, Silver SM. Applications of magnetic resonance spectroscopy to tinnitus research: initial data, current issues, and future perspectives. Prog Brain Res. 2007;166:71–81. doi: 10.1016/S0079-6123(07)66007-5.
    1. De Ridder D, Vanneste S, Weisz N, Londero A, Schlee W, Elgoyhen AB, Langguth B. An integrative model of auditory phantom perception: Tinnitus as a unified percept of interacting separable subnetworks. Neurosci Biobehav Rev. 2014;44:16–32. doi: 10.1016/j.neubiorev.2013.03.021.
    1. De Ridder D, Vanneste S, Langguth B, Llinas R. Thalamocortical dysrhythmia: a theoretical update in tinnitus. Front Neurol. 2015;6:124. doi: 10.3389/fneur.2015.00124.
    1. Edden RA, Barker PB. Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med. 2007;58:1276–1282. doi: 10.1002/mrm.21383.
    1. Edden RA, Puts NA, Barker PB. Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T. Magn Reson Med. 2012;68:657–661. doi: 10.1002/mrm.24391.
    1. Edden RA, Puts NA, Harris AD, Barker PB, Evans CJ. Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging. 2014;40:1445–1452. doi: 10.1002/jmri.24478.
    1. Eggermont JJ. Hearing loss, hyperacusis, or tinnitus: what is modeled in animal research? Hear Res. 2013;295:140–149. doi: 10.1016/j.heares.2012.01.005.
    1. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, Ludolph A, Klose U. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med. 2003;50:1296–1301. doi: 10.1002/mrm.10640.
    1. Gao F, Wang G, Ma W, Ren F, Li M, Dong Y, Liu C, Liu B, Bai X, Zhao B, Edden RA. Decreased auditory GABA+ concentrations in presbycusis demonstrated by edited magnetic resonance spectroscopy. Neuroimage. 2015;106:311–316. doi: 10.1016/j.neuroimage.2014.11.023.
    1. Gu JW, Halpin CF, Nam EC, Levine RA, Melcher JR. Tinnitus, diminished sound-level tolerance, and elevated auditory activity in humans with clinically normal hearing sensitivity. J Neurophysiol. 2010;104:3361–3370. doi: 10.1152/jn.00226.2010.
    1. Gutiérrez-Fernández M, Rodríguez-Frutos B, Fuentes B, Vallejo-Cremades MT, Alvarez-Grech J, Expósito-Alcaide M, Díez-Tejedor E. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int. 2012;60:310–317. doi: 10.1016/j.neuint.2011.12.015.
    1. Han SS, Nam EC, Won JY, Lee KU, Chun W, Choi HK, Levine RA. Clonazepam quiets tinnitus: a randomised crossover study with Ginkgo biloba. J Neurol Neurosurg Psychiatry. 2012;83:821–827. doi: 10.1136/jnnp-2012-302273.
    1. Harris AD, Puts NA, Edden RA. Tissue correction for GABA-edited MRS: considerations of voxel composition, tissue segmentation and tissue relaxations. J Magn Reson Imaging. 2015 doi: 10.1002/jmri.24903. doi: 10.1002/jmri.24903. Advance online publication. Retrieved October 8, 2015.
    1. Harris AD, Glaubitz B, Near J, John Evans C, Puts NA, Schmidt-Wilcke T, Tegenthoff M, Barker PB, Edden RA. Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med. 2014;72:941–948. doi: 10.1002/mrm.25009.
    1. Husain FT, Medina RE, Davis CW, Szymko-Bennett Y, Simonyan K, Pajor NM, Horwitz B. Neuroanatomical changes due to hearing loss and chronic tinnitus: a combined VBM and DTI study. Brain Res. 2011;1369:74–88. doi: 10.1016/j.brainres.2010.10.095.
    1. Khalfa S, Dubal S, Veuillet E, Perez-Diaz F, Jouvent R, Collet L. Psychometric normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat Spec. 2002;64:436–442. doi: 10.1159/000067570.
    1. Kilicarslan R, Alkan A, Aralasmak A, Aksoy F, Toprak H, Yetis H, Ozturan O. Magnetic resonance spectroscopy features of Heschl's gyri in patients with unilateral acoustic neuroma: preliminary study. Acad Radiol. 2014;21:1501–1505. doi: 10.1016/j.acra.2014.07.007.
    1. Lanting CP, De Kleine E, Bartels H, Van Dijk P. Functional imaging of unilateral tinnitus using fMRI. Acta Otolaryngol. 2008;128:415–421. doi: 10.1080/00016480701793743.
    1. Llano DA, Turner J, Caspary DM. Diminished cortical inhibition in an aging mouse model of chronic tinnitus. J Neurosci. 2012;32:16141–16148. doi: 10.1523/JNEUROSCI.2499-12.2012.
    1. Llinás RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A. 1999;96:15222–15227. doi: 10.1073/pnas.96.26.15222.
    1. Lockwood AH, Salvi RJ, Coad ML, Towsley ML, Wack DS, Murphy BW. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology. 1998;50:114–120. doi: 10.1212/WNL.50.1.114.
    1. Melcher JR, Levine RA, Bergevin C, Norris B. The auditory midbrain of people with tinnitus: abnormal sound-evoked activity revisited. Hear Res. 2009;257:63–74. doi: 10.1016/j.heares.2009.08.005.
    1. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998;11:266–272. doi: 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>%3B2-J.
    1. Middleton JW, Kiritani T, Pedersen C, Turner JG, Shepherd GM, Tzounopoulos T. Mice with behavioral evidence of tinnitus exhibit dorsal cochlear nucleus hyperactivity because of decreased GABAergic inhibition. Proc Natl Acad Sci U S A. 2011;108:7601–7606. doi: 10.1073/pnas.1100223108.
    1. Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 1996;58:1929–1935. doi: 10.1016/0024-3205(96)00182-8.
    1. Mlynárik V, Gruber S, Moser E. Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 2001;14:325–331. doi: 10.1002/nbm.713.
    1. Moazami-Goudarzi M, Michels L, Weisz N, Jeanmonod D. Temporo-insular enhancement of EEG low and high frequencies in patients with chronic tinnitus. QEEG study of chronic tinnitus patients. BMC Neurosci. 2010;11:40. doi: 10.1186/1471-2202-11-40.
    1. Mullins PG, McGonigle DJ, O'Gorman RL, Puts NA, Vidyasagar R, Evans CJ, Edden RA. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage. 2014;86:43–52. doi: 10.1016/j.neuroimage.2012.12.004.
    1. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med. 2001;31:269–286. doi: 10.1016/S0010-4825(01)00006-3.
    1. Near J, Edden R, Evans CJ, Paquin R, Harris A, Jezzard P. Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain. Magn Reson Med. 2014 doi: 10.1002/mrm.25094. doi: 10.1002/mrm.25094. Advance online publication. Retrieved October 8, 2015.
    1. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143–148. doi: 10.1001/archotol.1996.01890140029007.
    1. Noreña AJ, Eggermont JJ. Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear Res. 2003;183:137–153. doi: 10.1016/S0378-5955(03)00225-9.
    1. Noreña AJ, Farley BJ. Tinnitus-related neural activity: theories of generation, propagation, and centralization. Hear Res. 2013;295:161–171. doi: 10.1016/j.heares.2012.09.010.
    1. Puts NA, Edden RA. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc. 2012;60:29–41. doi: 10.1016/j.pnmrs.2011.06.001.
    1. Rae CD. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res. 2014;39:1–36. doi: 10.1007/s11064-013-1199-5.
    1. Sametsky EA, Turner JG, Larsen D, Ling L, Caspary DM. Enhanced GABAA-mediated tonic inhibition in auditory thalamus of rats with behavioral evidence of tinnitus. J Neurosci. 2015;35:9369–9380. doi: 10.1523/JNEUROSCI.5054-14.2015.
    1. Sedley W, Cunningham MO. Do cortical gamma oscillations promote or suppress perception? An under-asked question with an over-assumed answer. Front Hum Neurosci. 2013;7:595. doi: 10.3389/fnhum.2013.00595.
    1. Sedley W, Gander PE, Kumar S, Oya H, Kovach CK, Nourski KV, Kawasaki H, Howard MA, 3rd, Griffiths TD. Intracranial mapping of a cortical tinnitus system using residual inhibition. Curr Biol. 2015;25:1208–1214. doi: 10.1016/j.cub.2015.02.075.
    1. Seki S, Eggermont JJ. Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after localized tone-induced hearing loss. Hear Res. 2003;180:28–38. doi: 10.1016/S0378-5955(03)00074-1.
    1. Shulman A, Strashun AM, Seibyl JP, Daftary A, Goldstein B. Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J. 2000;6:98–111.
    1. Tass PA, Adamchic I, Freund HJ, von Stackelberg T, Hauptmann C. Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restor Neurol Neurosci. 2012;30:137–159. doi: 10.3233/RNN-2012-110218.
    1. Tkác I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 1999;41:649–656. doi: 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>%3B2-G.
    1. Vanneste S, Plazier M, der Loo Ev, de Heyning PV, Congedo M, De Ridder D. The neural correlates of tinnitus-related distress. Neuroimage. 2010;52:470–480. doi: 10.1016/j.neuroimage.2010.04.029.
    1. Wang XC, Du XX, Tian Q, Wang JZ. Correlation between choline signal intensity and acetylcholine level in different brain regions of rat. Neurochem Res. 2008;33:814–819. doi: 10.1007/s11064-007-9509-4.
    1. Weisz N, Müller S, Schlee W, Dohrmann K, Hartmann T, Elbert T. The neural code of auditory phantom perception. J Neurosci. 2007;27:1479–1484. doi: 10.1523/JNEUROSCI.3711-06.2007.
    1. Zheng Y, Vagal S, McNamara E, Darlington CL, Smith PF. A dose-response analysis of the effects of L-baclofen on chronic tinnitus caused by acoustic trauma in rats. Neuropharmacology. 2012;62:940–946. doi: 10.1016/j.neuropharm.2011.09.027.

Source: PubMed

3
Prenumerera